FDA commissioner watch intensifies as FDA reform bill nears completion.
This article was originally published in The Rose Sheet
Executive Summary
FDA COMMISSIONER WATCH INTENSIFIES AS FDA REFORM BILL NEARS COMPLETION; passage of FDA reform legislation may trigger a White House nomination for senatorial confirmation hearings. Any delay would suggest that the nomination of HHS' preferred candidate, FDA Lead Deputy Commissioner Michael Friedman, MD, has run into some roadblocks.